LFG
JBIO

Larson Financial Group’s Jade Biosciences JBIO Stock Holding History

Larson Financial Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46K Buy
104
+81
+352% +$1.17K ﹤0.01% 3057
2025
Q4 		$355 Buy
+23
New +$270 ﹤0.01% 3186

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Larson Financial Group's JBIO Position: Q1 2026 in Review

Larson Financial Group increased its Jade Biosciences (JBIO) stake by 352% in Q1 2026, buying an estimated $1.17K and bringing the position to 104 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3057.

Larson Financial Group first reported a position in JBIO in Q4 2025 and has held it in 2 quarters since. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Larson Financial Group held 104 shares of Jade Biosciences worth $1.46K as of Q1 2026.
  • Larson Financial Group bought 81 Jade Biosciences shares in Q1 2026, an estimated $1.17K.
  • Jade Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3057 holding.
  • Larson Financial Group first reported a position in Jade Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.